Invokana Lawsuit Plaintiffs Observe ISMP Reports Linking Invokana To 168 Cases Of Metabolic Acidosis

March 21, 2016 – – TheProductLawyers.com report on more than 150 adverse event reports which have been made to U.S. Food and Drug Administration (FDA) regarding patients who have taken type-2 diabetes drug Invokana and who have subsequently developed metabolic acidosis. Metabolic acidosis is a potentially life-threatening condition in which the body’s bloodstream contains too much toxic acid (ketones). Details of these concerning adverse event reports were listed In a QuarterWatch report from the Institute for Safe Medication Practices. It was additionally indicated that the FDA has received 5,500 adverse event reports discussing Invokana and its potential side effects.

Invokana was the first drug to be released from a group of similar diabetes drugs called SGLT2 class inhibitors. It came on the market in 2013 after approval from the FDA. Several of the SGLT2 class inhibitor drugs have been linked to similar adverse event reports, however, Invokana currently has the most reports associated with it. The U.S. Food and Drug Administration has actively addressed this issue with the public and has asked those taking Invokana to carefully watch for any signs and symptoms which may indicate that they are developing metabolic acidosis. They issued a public safety communication recently discussing several health problems associated with Invokana and also requiring that manufacturer Janssen Pharmaceuticals (a subdivision of Johnson & Johnson corporation) make some necessary changes to the drug’s warning label to better reflect possible risks.

As the adverse event reports are becoming more publicly discussed, patients using the drug have understandably become concerned for their safety, and lawsuits discussing Invokana have even begun to appear. The attorneys of Banville Law are currently working to assist the public by keeping them fully informed regarding new information on the topic. To help accomplish this, they now sponsor online resource website TheProductLawyers.com. The attorneys of Banville Law are also assisting patients who took Invokana and who suffered from a variety of health problems which they believe were caused by the drug. These patients may be entitled to significant compensation, and are certainly entitled to the opportunity of fully evaluating their legal rights. To help those looking to pursue justice, Banville Law is currently offering complimentary legal consultations for affected parties.

To request additional information, or to ask questions concerning Invokana lawsuits, please contact the attorneys of Banville Law by calling 877-671-6480.

###

Contact TheProductLawyers.com:

Banville Law
877-671-6480
info@banvillelaw.com
165 West End Ave #1h,
New York, NY 10023

ReleaseID: 60008799